Phathom Pharmaceuticals, Inc. PHAT
NASDAQ · United States · Health Technology
$7.08-0.22 (-3.01%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | -0.21 | -0.18 | -19.6% | $74.27M | +1.4% | -24.8%$11.64→$8.75 |
| Q1 2026 | 2026-04-30 | -0.25 | -0.27 | +7.4% | — | — | +2.0%$11.78→$12.01 |
| Q4 2025 | 2026-02-26 | -0.16 | -0.20 | +20.0% | — | — | +1.9%$12.32→$12.56 |
| Q3 2025 | 2025-10-30 | -0.28 | -0.40 | +30.0% | — | — | +0.1%$13.53→$13.55 |
| Q4 2024 | 2025-03-06 | -1.05 | -1.08 | +2.8% | — | — | — |
| Q4 2023 | 2024-03-07 | -0.80 | -1.00 | +20.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.